Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases
NCT05251415 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2026-03-17
Summary
The aim of this project is to start a biological and clinical collection of patients presenting systemic autoimmune disease. This collection will provide appropriate biological samples to identify new biomarkers and to be accessible to the medical, scientific and industrial communities for the identification of new therapeutic strategies
Conditions
- Lupus Erythematosus
- Scleroderma
- Myositis
- Vasculitis
- Inflammatory Bowel Diseases
Interventions
- BIOLOGICAL
-
Blood sampling
Blood will be taken in larger quantity.
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Chloé BOST, MD, PhD · University Hospital, Toulouse
Eligibility
- Min Age
- 6 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-04
- Primary Completion
- 2027-04-04
- Completion
- 2032-04-04
Countries
- France
Study Locations
More Related Trials
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
NCT02890121 ·Status: COMPLETED
-
Catalytic Antibodies and Lupus in Martinique
NCT01157468 ·Status: COMPLETED
-
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
NCT02890147 ·Status: COMPLETED
-
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis
NCT03575156 ·Status: COMPLETED ·Phase: NA
-
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines
NCT04951427 ·Status: UNKNOWN
-
Disease Activity Biomarkers in Patients With Systemic Lupus Erythematosus
NCT05443516 ·Status: RECRUITING
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of Lipids in Immune Cell Function in SLE Patients
NCT04361734 ·Status: UNKNOWN
-
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism
NCT05961267 ·Status: COMPLETED
-
Study of Leukocyte Populations in Patients With Chronic Inflammatory
NCT04749875 ·Status: NOT_YET_RECRUITING
-
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus
NCT05179018 ·Status: UNKNOWN
-
Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)
NCT05394922 ·Status: RECRUITING
-
Disease Progression and Activity in Patients With Systemic Lupus Erythematosus
NCT00339261 ·Status: COMPLETED
-
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322)
NCT05193591 ·Status: RECRUITING
-
Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus.
NCT02891213 ·Status: UNKNOWN
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Regulatory BCells in Systemic Lupus Erythematosus
NCT03178721 ·Status: UNKNOWN
-
LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse
NCT02811094 ·Status: TERMINATED ·Phase: NA
-
Clinical Autoinflammatory Disease Cohort
NCT07126145 ·Status: NOT_YET_RECRUITING
-
Auto-immune Diseases and Quality of Life
NCT02855840 ·Status: COMPLETED
-
Anti-ficolin-2 Autoantibodies in Lupus Nephritis
NCT03063281 ·Status: COMPLETED
-
Anti-ficolin-3 Autoantibodies in Lupus Nephritis
NCT02625831 ·Status: COMPLETED
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
NCT05022420 ·Status: RECRUITING
-
Estimate of the Activity and the Forecast of the Lupus Disease of the Adult by a Transcriptomic Score (STUDY LU-PUCE)
NCT00920114 ·Status: COMPLETED ·Phase: NA